1. Academic Validation
  2. Click-Particle Display for Base-Modified Aptamer Discovery

Click-Particle Display for Base-Modified Aptamer Discovery

  • ACS Chem Biol. 2019 Dec 20;14(12):2652-2662. doi: 10.1021/acschembio.9b00587.
Chelsea K L Gordon Diana Wu Anusha Pusuluri Trevor A Feagin Andrew T Csordas Michael S Eisenstein Craig J Hawker Jia Niu 1 Hyongsok Tom Soh 2
Affiliations

Affiliations

  • 1 Department of Chemistry , Boston College , Chestnut Hill , Massachusetts 02467 , United States.
  • 2 Chan Zuckerberg Biohub , San Francisco , California 94158 , United States.
Abstract

Base-modified Aptamers that incorporate non-natural chemical moieties can achieve greatly improved affinity and specificity relative to natural DNA or RNA Aptamers. However, conventional methods for generating base-modified Aptamers require considerable expertise and resources. In this work, we have accelerated and generalized the process of generating base-modified Aptamers by combining a click-chemistry strategy with a fluorescence-activated cell sorting (FACS)-based screening methodology that measures the affinity and specificity of individual Aptamers at a throughput of ∼107 per hour. Our "click-particle display (PD)" strategy offers many advantages. First, almost any chemical modification can be introduced with a commercially available polymerase. Second, click-PD can screen vast numbers of individual Aptamers on the basis of quantitative on- and off-target binding measurements to simultaneously achieve high affinity and specificity. Finally, the increasing availability of FACS instrumentation in academia and industry allows for easy adoption of click-PD in a broader scientific community. Using click-PD, we generated a boronic acid-modified aptamer with ∼1 μM affinity for epinephrine, a target for which no aptamer has been reported to date. We subsequently generated a mannose-modified aptamer with nanomolar affinity for the lectin concanavalin A (Con A). The strong affinity of both Aptamers is fundamentally dependent upon the presence of chemical modifications, and we show that their removal essentially eliminates aptamer binding. Importantly, our Con A aptamer exhibited exceptional specificity, with minimal binding to Other structurally similar lectins. Finally, we show that our aptamer has remarkable biological activity. Indeed, this aptamer is the most potent inhibitor of Con A-mediated hemagglutination reported to date.

Figures
Products